Topics

Companies Related to "Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy" [Most Relevant Company Matches] RSS

01:17 EST 20th January 2020 | BioPortfolio

Here are the most relevant search results for "Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy" found in our extensive corporate database of over 50,000 company records.

Showing "Focal Brachytherapy Boost Stereotactic Radiotherapy" Companies 1–25 of 147

Relevant

CET CANCER CENTER

California Endocurietherapy Cancer Center (CET) is the first brachytherapy only center in the United States.Founded by D Jeffrey Demanes M.D. in 1981.Dedicated solely to High Dose Rate brachytherapy (HDR) since 1991.Most experienced HDR brachytherapy center.A training destination for physicians and residents.HDR treatment protocol developmentInnovation in high dose rate brachytherapy and equipment...


GammaWest Brachytherapy

Brachytherapy is an advanced cancer treatment. The word "brachy" is Greek for "close by" and refers to placing radioactive seeds or sources directly in the tumor. This procedure gives physicians and patients the important advantage of applying a higher dose of radiation directly to the tumor while sparing healthy tissue and surrounding organs. Brachytherapy is a localized, precise, radiation treat...

IsoRay Inc.

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed, used to treat prostate and other cancers. The Cesium-131 seed offers a significantly shorter half-life than the two other isotopes commonly used for brachytherapy, which results in a substantially faster delivery of therapeutic radiation, ...


Psimei Pharmaceuticals plc

Psimei Pharmaceuticals plc, founded in 2001, is a world leader in the development of Boron Cellular Radiotherapy (BCR) products. These are designed to significantly improve the clinical effectiveness of radiotherapy in the treatment of cancer. At present only 30% of cancer patients receiving radiotherapy are "cured". This equates to complete clinical responses for up to 5 years. Psimei is currentl...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

CivaTech Oncology Inc.

CivaTech Oncology Inc. develops improved low dose rate (LDR) brachytherapy devices. Our first device, the CivaString™, has been cleared by the FDA for use in localized tumors. The Company is also developing innovative implantable bioabsorbable brachytherapy products for the treatment of breast, lung and other cancers.

Focal Therapeutics

Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides radiographic marking of soft tissue sites. The BioZorb device is placed at the time of surgical removal of tissue, such as during breast surgery, and the device’s three-dimens...

Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) is a late stage development company engaged in the development of brachytherapy devices for therapeutic applications. AMIC's focus is on transitioning to full operations upon receipt of FDA clearance for its patented brachytherapy cancer products. Brachytherapy uses radiation to destroy cancerous tumors by placin...

Nucletron

Nucletron provides state of the art radiotherapy solutions for cancer treatment that meet the evolving needs of patients, their carers and healthcare professionals around the world. Nucletron has unmatched global leadership in brachytherapy, a very precise, highly effective and well-tolerated treatment option for healthcare providers, tailored to the needs of individual patients. We work with ...

PAR Scientific A/S

PAR Scientific A/S was founded 1986 in Denmark. We are a subsidiary of S&S X-Ray Products Inc., USA. All development activities, both mechanical, electronics and software are taking place in Denmark. We manufacture high technology equipment for optimization of radiotherapy treatment and have more than 650 units installed in 375 radiotherapy centres throughout the world. Our Ideology is to develop,...

Prostate Brachytherapy Advisory Group

SOURCE Prostate Brachytherapy Advisory Group

Augmenix, Inc.

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or efficacy. Augmenix's first product, SpaceOAR system is an injectable tissue spacer that will decrease rectal morbidity or enable improved efficacy in prostate radiotherapy. The company was founded in ...

Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...

Focal Pointe Data Solutions

Headquartered in Carlsbad, Calif., Focal Pointe Data Solutions, LLC is a service technology company providing data management, analytics and business intelligence solutions for hospitals. The company’s strength is its ability to transform raw data into actionable information that is meaningful for clients and their users. This information is used to i...

Mick Radio-Nuclear Instruments, Inc.

Mick Radio-Nuclear Instruments, Inc., known internationally for its 30+ years of service to the Radiation Therapy community, provides high-quality and state-of-the-art instrumentation and accessories encompassing the entire spectrum of Radiation Therapy. Products are manufactured in an ISO Certified facility in accordance with the requirements of ISO 13485:2003. All Mick products are FDA 510 (k) a...

Devicor® Medical Products, Inc.

Devicor Medical Products, headquartered in Cincinnati, Ohio, has more than 400 employees around the world. As the global market leader, Devicor is committed to advancing technology to help clinicians accurately diagnose breast disease, such as breast cancer, through minimally invasive procedures. Devicor’s product portfolio includes the world-renowned...

Concord Medical Services Holdings Limited

Concord Medical operates the largest network of radiotherapy and diagnostic imaging facilities in China in terms of revenues and the total number of facilities in operation per available statistics. The Company currently operates a network of more than 89 centers spanning 37 cities and 21 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in Chi...

RC Cancer Centers

Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its ...

NOVOSTE

Novoste Corporation, based in Atlanta, Georgia, develops advanced medical treatments for coronary and vascular diseases and is the worldwide leader in vascular brachytherapy - radiation therapy delivered inside a blood vessel to prevent its reclosure (restenosis) following balloon angioplasty and other catheter-based interventional procedures. The NovosteT Beta-CathT System is commercially availab...

Theragenics Corporation®

Theragenics Corporation (NYSE: TGX) operates two business segments: its surgical products business and its brachytherapy seed business. The surgical products business (www.cpmedical.com, www.galtmedical.com, www.needletech.com) manufactures and distributes wound closure, vascular access, and specialty needle products. Wound closure products include ...

IsoRay, Inc.

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com.

Nucletron Corporation

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Nucletron Corporation (HQ)

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Nucletron Corporation (UK)

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment.

Xoft Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader spectrum of patients and their physicians. The Axxent treat...


More From BioPortfolio on "Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy"

Quick Search

Corporate Database Quicklinks